Evidence map›Paper›PMID 37663673›Full record

ArticleHemaSphere2023

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.

Kazimierz Groen, Fredrik H Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R Seefat, Markus Hansson, Maria B L Leys, Josien C Regelink, Anders Waage, Damian Szatkowski and 15 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 4 countries.

Kazimierz GroenDepartment of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.
Fredrik H SchjesvoldDepartment of Hematology, Oslo Myeloma Center, Oslo University Hospital, Norway.
Bronno van der HoltDepartment of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Mark-David LevinDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Maarten R SeefatDepartment of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.
Markus HanssonDepartment of Hematology, Skåne University Hospital Lund, Sweden.
Maria B L LeysDepartment of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.
Josien C RegelinkDepartment of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands.
Anders WaageInstitute of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Damian SzatkowskiDepartment of Oncology and Hematology, Førde Central Hospital, Norway.
Per AxelssonDepartment of Internal Medicine, Helsingborg Hospital, Sweden.
Trung Hieu DoHaematology Department H 60, Roskilde Sjaelland University, Denmark.
Asta SvirskaiteDepartment of Hematology, Aalborg University Hospital, Denmark.
Ellen van der SpekDepartment of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
Einar HaukasDepartment for Blood and Cancer Diseases, Stavanger University Hospital, Norway.
Dorota Knut-BojanowskaInstitute of Heamatology, Uddevalla Hospital, Sweden.
Paula F YpmaDepartment of Hematology, Haga Hospital, The Hague, the Netherlands.
Cecilie H BlimarkHematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden.
Ulf-Henrik MellqvistDepartment of Internal Medicine, Sodra Alvsborgs Sjukhus, Boras, Sweden.
Niels W C J van de DonkDepartment of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Anja KlostergaardDepartment of Hematology, Aarhus University Hospital, Denmark.
Annette J VangstedDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark.
Niels AbildgaardDepartment of Hematology, Hematology Research Unit and Academy of Geriatric Research, Odense University Hospital and University of Southern Denmark, Denmark.
Sonja ZweegmanDepartment of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.
Amsterdam University Medical Centers · NLErasmus MC Cancer Institute · NLVrije Universiteit Amsterdam · NLAalborg University Hospital · DKAarhus University Hospital · DKAlbert Schweitzer Ziekenhuis · NLHaga Hospital · NLHelse Førde · NOHelsingborgs lasarett · SEMaasstad Ziekenhuis · NLMeander Medisch Centrum · NLNorwegian University of Science and Technology · NORigshospitalet · DKRijnstate Hospital · NLSahlgrenska University Hospital · SESkåne University Hospital · SESödra Älvsborg Hospital · SEStavanger University Hospital · NOUddevalla sjukhus · SEUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37663673
PMCPMC10470677
OpenAlexW4386287281

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.